tm logo
Trademark Search
Design & PHARMA Inventor (with a maple leaf on the top of I)
Design & PHARMA Inventor (with a maple leaf on the top of I)
DEFAULT - SEARCHED

on 31 Dec 1969

Last Applicant/ Owned by

Pharma Inventor Inc.

3800 Wesbrook MallSuite 215Vancouver

BRITISH COLUMBIA

CA

V6S2L9

Serial Number

2221327 filed on 09th Nov 2022

Design & PHARMA Inventor (with a maple leaf on the top of I)

Vienna Information


5 . 3 . 4

Vine leaves (except 5.3.19), plane leaves, maple leavesFeuilles de vigne (excepté 5.3.19), de platane, d'érable

5 . 3 . 14

One leafUne feuille

5 . 3 . 50

11-pointed Canadian maple leaf (leaves)Feuille d'érable du Canada à onze pointes

24 . 15 . 1

One arrowUne flèche

24 . 15 . 8

Arrows combined with any other inscription (except a 24.15.17)Flèches combinées avec une autre inscription (excepté a 24.15.17)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

26 . 1 . 1

CirclesCercles

26 . 1 . 4

Two circles, two ellipses, one inside the otherDeux cercles, deux ellipses, l'un dans l'autre

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 22

Monograms formed of intertwined, overlapping or otherwise combined lettersMonogrammes formés par des lettres enlacées, se chevauchant ou combinées autrement

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 8

BlackNoir

Trademark usage description

alcohol screening for scientific research purposes; allergy testing for scientific research purposes; analysis and evaluation of product development; Read More

Classification Information


Class [042]
Alcohol screening for scientific research purposes; allergy testing for scientific research purposes; analysis and evaluation of product development; analysis for oil research; analysis in the field of molecular biology; analysis of proteins for scientific and medical research purposes; application service provider (ASP) for searching structured and unstructured data for healthcare data analytics; assessment of chemical information to estimate levels of risk; basic and clinical research in the field of respiratory science and medicine; biochemical analysis; biochemical research; biochemical research and analysis; biomedical research; biomedical research services; calibration of laboratory equipment; chemical analysis; chemical engineering; chemical laboratories; chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; chemical research; chemist services; consultancy in the field of biochemistry; consultancy in the field of chemistry; consulting services in the field of pharmaceutical research; consumer product safety testing consultation; consumer product safety testing services; custom design and development of chemical reagents and biochemical assays; custom design and development of food formulation compounds for use in the food industry; custom design and development of safe chemical and biological agent simulants for use in air quality measurement; drug discovery services; drug screening for scientific research purposes; environmental assessment services; environmental testing services to detect contaminants in water; evaluating and testing the environmental qualities and impact of consumer products of others; food safety testing and consultation; laboratory research in the field of chemistry; laboratory research in the field of pharmaceuticals and nutraceuticals; laboratory testing of materials; pharmaceutical drug development services; pharmaceutical evaluation services; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; pharmacological research services; preparation of reports relating to chemical research; providing information about medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing quality assurance in the food industry; providing quality control for the food industry; providing scientific information in the field of climate change; providing scientific information in the field of global warming; providing scientific information in the fields of climate change and global warming; providing scientific information, advice and consultancy relating to carbon offsetting; providing scientific research information in the fields of biomedicine; providing scientific research information in the fields of clinical trials and post-market trials; providing scientific research information in the fields of pharmaceuticals; quality assurance testing of fuel cell and hydrogen products of others; quality control testing of anti-corrosion materials; quality control testing of insulating materials; quality control testing of non-combustible materials; research and design in the field of chemistry; research and design in the field of medicine; research and development of new products for others; research and development of vaccines and medicines; research and development services in the field of immunology; research and development services in the field of nutritional supplements; research and testing in the field of bacteriology; research in the field of artificial intelligence technology; research in the field of biochemistry; research in the field of chemistry; research in the field of ecology; research in the field of environmental conservation; research in the field of environmental protection; research in the fields of biologic therapeutic preparations; research in the fields of clinical trials and post-market trials; research in the reduction of carbon emissions; research on the subject of pharmaceuticals; scientific and technological research relating to patent mapping; scientific research consulting in the field of agricultural fertilization; scientific research consulting in the field of agricultural irrigation; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the field of oncology; scientific research in the field of drug metabolite synthesis; scientific research in the field of epidemiology; scientific research in the field of genetics and genetic engineering; scientific research in the field of in vitro drug metabolism systems; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; scientific research in the field of production of recombinant protein; scientific research services in the field of pharmacovigilance; soil analysis; technical development of prescription drug programs designed to process claims for medical products used by consumers; testing of human tissues and stem cells for scientific research purposes


Classification kind code

11

Mark Details


Serial Number

2221327

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 14
on 20th Nov 2024
Default Notice Sent
Submitted for opposition 22
on 02th May 2024
Search Recorded
Submitted for opposition 20
on 02th May 2024
Examiner's First Report
Submitted for opposition 30
on 09th Nov 2022
Filed
Submitted for opposition 1
on 09th Nov 2022
Created
Submitted for opposition 31
on 09th Nov 2022
Formalized